Wasita W Parksook1,2, Mahyar Heydarpour1, Shadi K Gholami1, James M Luther3, Paul N Hopkins4, Luminita H Pojoga1, Jonathan S Williams1. 1. Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. 2. Department of Medicine (Division of Endocrinology and Metabolism, and Division of General Internal Medicine), Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand. 3. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Hypertension Center, Nashville, Tennessee 37232, USA. 4. Cardiovascular Genetics Research Unit, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
Abstract
CONTEXT: Salt sensitivity of blood pressure (SSBP) is associated with increased cardiovascular risk, especially in individuals of African descent, although the underlying mechanisms remain obscure. Lysine-specific demethylase 1 (LSD1) is a salt-sensitive epigenetic regulator associated with SSBP and aldosterone dysfunction. An LSD1 risk allele in humans is associated with SSBP and lower aldosterone levels in hypertensive individuals of African but not European descent. Heterozygous knockout LSD1 mice display SSBP and aldosterone dysregulation, but this effect is modified by age and biological sex. This might explain differences in cardiovascular risk with aging and biological sex in humans. OBJECTIVE: This work aims to determine if LSD1 risk allele (rs587618) carriers of African descent display a sex-by-age interaction with SSBP and aldosterone regulation. METHODS: We analyzed 297 individuals of African and European descent from the HyperPATH cohort. We performed multiple regression analyses for outcome variables related to SSBP and aldosterone. RESULTS: LSD1 risk allele carriers of African (but not European) descent had greater SSBP than nonrisk homozygotes. Female LSD1 risk allele carriers of African descent had greater SSBP, mainly relationship-driven by women with low estrogen (postmenopausal). There was a statistically significant LSD1 genotype-sex interaction in aldosterone response to angiotensin II stimulation in individuals aged 50 years or younger, with female carriers displaying decreased aldosterone responsiveness. CONCLUSION: SSBP associated with LSD1 risk allele status is driven by women with a depleted estrogen state. Mechanisms related to a resistance to develop SSBP in females are uncertain but may relate to an estrogen-modulating effect on mineralocorticoid receptor (MR) activation and/or LSD1 epigenetic regulation of the MR.
CONTEXT: Salt sensitivity of blood pressure (SSBP) is associated with increased cardiovascular risk, especially in individuals of African descent, although the underlying mechanisms remain obscure. Lysine-specific demethylase 1 (LSD1) is a salt-sensitive epigenetic regulator associated with SSBP and aldosterone dysfunction. An LSD1 risk allele in humans is associated with SSBP and lower aldosterone levels in hypertensive individuals of African but not European descent. Heterozygous knockout LSD1 mice display SSBP and aldosterone dysregulation, but this effect is modified by age and biological sex. This might explain differences in cardiovascular risk with aging and biological sex in humans. OBJECTIVE: This work aims to determine if LSD1 risk allele (rs587618) carriers of African descent display a sex-by-age interaction with SSBP and aldosterone regulation. METHODS: We analyzed 297 individuals of African and European descent from the HyperPATH cohort. We performed multiple regression analyses for outcome variables related to SSBP and aldosterone. RESULTS: LSD1 risk allele carriers of African (but not European) descent had greater SSBP than nonrisk homozygotes. Female LSD1 risk allele carriers of African descent had greater SSBP, mainly relationship-driven by women with low estrogen (postmenopausal). There was a statistically significant LSD1 genotype-sex interaction in aldosterone response to angiotensin II stimulation in individuals aged 50 years or younger, with female carriers displaying decreased aldosterone responsiveness. CONCLUSION: SSBP associated with LSD1 risk allele status is driven by women with a depleted estrogen state. Mechanisms related to a resistance to develop SSBP in females are uncertain but may relate to an estrogen-modulating effect on mineralocorticoid receptor (MR) activation and/or LSD1 epigenetic regulation of the MR.
Authors: Yuefei Huang; Pei Yee Ting; Tham M Yao; Tsuyoshi Homma; Danielle Brooks; Isis Katayama Rangel; Gail K Adler; Jose R Romero; Jonathan S Williams; Luminita H Pojoga; Gordon H Williams Journal: J Endocrinol Date: 2019-02-01 Impact factor: 4.286
Authors: Zeng Guo; Marko Poglitsch; Brett C McWhinney; Jacobus P J Ungerer; Ashraf H Ahmed; Richard D Gordon; Martin Wolley; Michael Stowasser Journal: J Clin Endocrinol Metab Date: 2018-11-01 Impact factor: 5.958
Authors: Wanzhu Tu; George J Eckert; Tamara S Hannon; Hai Liu; Linda M Pratt; Mary Anne Wagner; Linda A Dimeglio; Jeesun Jung; J Howard Pratt Journal: Hypertension Date: 2014-04-07 Impact factor: 10.190
Authors: Clarence E Grim; Allen W Cowley; Pavel Hamet; Daniel Gaudet; Mary L Kaldunski; Jane Morley Kotchen; Shanthi Krishnaswami; Zdenka Pausova; Richard Roman; Johanne Tremblay; Theodore A Kotchen Journal: Hypertension Date: 2005-02-07 Impact factor: 10.190
Authors: Bradley R Javorsky; Hershel Raff; Ty B Carroll; Alicia Algeciras-Schimnich; Ravinder Jit Singh; Jessica M Colón-Franco; James W Findling Journal: J Endocr Soc Date: 2021-02-18
Authors: Wasita W Parksook; Mahyar Heydarpour; Shadi K Gholami; James M Luther; Paul N Hopkins; Luminita H Pojoga; Jonathan S Williams Journal: J Clin Endocrinol Metab Date: 2022-04-19 Impact factor: 6.134